Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Revenue

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹11,813 Cr₹11,583 Cr₹12,305 Cr₹10,944 Cr₹10,641 Cr

What is the latest Revenue of GLENMARK PHARMACEUTICALS ?

The latest Revenue ratio of GLENMARK PHARMACEUTICALS is ₹11,813 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹11,813 Cr
Mar2024₹11,583 Cr
Mar2023₹12,305 Cr
Mar2022₹10,944 Cr
Mar2021₹10,641 Cr

How is Revenue of GLENMARK PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹11,813 Cr
1.98
Mar2024 ₹11,583 Cr
-5.86
Mar2023 ₹12,305 Cr
12.44
Mar2022 ₹10,944 Cr
2.85
Mar2021 ₹10,641 Cr -

Compare Revenue of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,701.6 Cr -3.2% 7.6% 51.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,782.0 Cr -2.5% 4.7% 7.1% Stock Analytics
DIVIS LABORATORIES ₹163,125.0 Cr -2.1% -0.2% 7.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,252.0 Cr -3.4% 0.7% 39.1% Stock Analytics
DR REDDYS LABORATORIES ₹108,025.0 Cr -1.9% 2% 16.1% Stock Analytics
CIPLA ₹102,443.0 Cr -4.3% -6.5% -11.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-3.2%

7.6%

51.1%

SENSEX

-0.2%

-7.2%

3.5%


You may also like the below Video Courses